CERO THERAPEUTICS HOLDINGS, INC.·4

Jan 9, 4:30 PM ET

Pierce Kristen 4

4 · CERO THERAPEUTICS HOLDINGS, INC. · Filed Jan 9, 2026

Insider Transaction Report

Form 4
Period: 2026-01-07
Pierce Kristen
Chief Development Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2026-01-07+1,612,0991,612,099 total
    Exercise: $0.06From: 2026-01-07Exp: 2036-01-06Common Stock (1,612,099 underlying)

Documents

1 file
  • 4
    ownership.xmlPrimary